LOS ANGELES, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY, founded in 2021, is a community nonprofit in the Medical Research sector that reported $1.1M in total revenue in fiscal year 2022. The organization ran a surplus of $175K, a strong 16% operating margin.
TO DEEPLY DECODE THE WORKINGS OF THE HUMAN IMMUNE SYSTEM TO PROMOTE HEALTH, COMBAT DISEASE AND PROLONG LIFE
THE INSTITUTE IS A MEDICAL SCIENCES RESEARCH INSTITUTE DEDICATED TO THE STUDY OF THE IMMUNE SYSTEM AND ITS VARIED ROLES IN THE PATHOGENESIS AND POTENTIAL TREATMENT OF A WIDE VARIETY OF DISEASES, WITH...
THE INSTITUTE IS A MEDICAL SCIENCES RESEARCH INSTITUTE DEDICATED TO THE STUDY OF THE IMMUNE SYSTEM AND ITS VARIED ROLES IN THE PATHOGENESIS AND POTENTIAL TREATMENT OF A WIDE VARIETY OF DISEASES, WITH A MISSION TO DEEPLY DECODE THE WORKINGS OF THE HUMAN IMMUNE SYSTEM TO PROMOTE HEALTH, COMBAT DISEASE AND PROLONG LIFE. THE INSTITUTE WAS ESTABLISHED TO CREATE A MULTIDISCIPLINARY MEDICAL RESEARCH INSTITUTE TO COORDINATE RESEARCH INTO THE HUMAN IMMUNE SYSTEM ACROSS UNIVERSITIES AND RESEARCH INSTITUTIONS IN CALIFORNIA. THE INSTITUTE ALSO PLANS TO ENGAGE IN THE CONTINUOUS AND ACTIVE CONDUCT OF MEDICAL RESEARCH IN COLLABORATION WITH VARIOUS NONPROFIT HOSPITALS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2022 | 2021 | Change | |
|---|---|---|---|
| Revenue | $1,108,746 | N/A | N/A |
| Expenses | $933,834 | N/A | N/A |
| Net Income | $174,912 | $0 | N/A |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| GARY MICHELSON | BOARD CHAIR/DIRECTOR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ERIC ESRAILIAN | PRESIDENT/DIRECTOR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MEYER LUSKIN | TREASURER/SECRETARY/DIRECTOR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ARIE BELLDEGRUN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL MILKEN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SEAN PARKER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | No data | No data | No data | No data |
| 2023 | $1,108,746 | $933,834 | $192,284 | $174,912 |
Compare INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY with other nonprofits in California and across the country.